Duoli Xie

1.2k total citations
20 papers, 616 citations indexed

About

Duoli Xie is a scholar working on Molecular Biology, Rheumatology and Hematology. According to data from OpenAlex, Duoli Xie has authored 20 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Rheumatology and 5 papers in Hematology. Recurrent topics in Duoli Xie's work include Rheumatoid Arthritis Research and Therapies (6 papers), Protein Degradation and Inhibitors (3 papers) and Multiple Myeloma Research and Treatments (2 papers). Duoli Xie is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (6 papers), Protein Degradation and Inhibitors (3 papers) and Multiple Myeloma Research and Treatments (2 papers). Duoli Xie collaborates with scholars based in China, Hong Kong and United States. Duoli Xie's co-authors include Lin Huang, Chengping Wen, Tieliu Shi, Huanlong Liu, Yan Shi, Aiping Lü, Chao Liang, Zhuqian Wang, Jie Huang and Dongyi He and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Nature Communications.

In The Last Decade

Duoli Xie

19 papers receiving 608 citations

Peers

Duoli Xie
Comparison fields: 5 of 89
  • Molecular Biology 297
  • Pharmacology 139
  • Complementary and alternative medicine 126
  • Computational Theory and Mathematics 79
  • Pharmacology 77
Replace Shujun Wei with:
Shujun Wei China
Dake Cai China
Kaihuan Wang China
Xiaojiao Duan China
Lin Ye China
Shengnan Wang China
Yanting You China
Xin Ba China
František Dráfi Slovakia
Pei Xiao China
Shujun Wei China View profile →
Citations per field, relative to Duoli Xie
Duoli Xie · 1×
Citations per year, relative to Duoli Xie
Duoli Xie · 1×

Countries citing papers authored by Duoli Xie

Since Specialization
Citations

This map shows the geographic impact of Duoli Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duoli Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duoli Xie more than expected).

Fields of papers citing papers by Duoli Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Duoli Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duoli Xie. The network helps show where Duoli Xie may publish in the future.

Co-authorship network of co-authors of Duoli Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Duoli Xie. A scholar is included among the top collaborators of Duoli Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Duoli Xie. Duoli Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 4
3 13
4 14
5 20
6 9
7 6
8 4
9 21
10 4
11 31
12 34
13 19
14 49
15 36
16 15
17 296
18 6
19 4
20 31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026